This inventor holds 3 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 3 EPO patents. Top assignees: China Medical University, China Medical University Hospital, The University of North Carolina at Chapel Hill. Active years: 2016-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 110 
1 out of 21 
1 out of 1,326 
Years Active: 2016-2020
Title: Ling-Chu Chang: Innovator in Anticancer Research
Introduction
Ling-Chu Chang is a prominent inventor based in Taichung, Taiwan. He has made significant contributions to the field of anticancer research, holding a total of 3 patents. His work focuses on developing novel compounds that show promise in treating various types of cancer.
Latest Patents
One of his latest patents involves derivatives of curcuminoids and their use as anticancer agents. This series of novel bis(hydroxymethyl) alkanoate derivatives of curcuminoids has demonstrated anticancer activity, particularly against breast cancer, colon cancer, and prostate cancer. Another notable patent relates to novel 20-sulfonylamidine derivatives of camptothecin, which includes methods of synthesizing these compounds and their application as antitumor agents for treating nasopharyngeal, lung, breast, or prostate cancer.
Career Highlights
Ling-Chu Chang has worked with esteemed institutions such as China Medical University and China Medical University Hospital. His research has significantly advanced the understanding and treatment of cancer through innovative chemical compounds.
Collaborations
He has collaborated with notable colleagues, including Sheng-Chu Kuo and Min-Tsang Hsieh, contributing to a rich environment of research and development in the field of oncology.
Conclusion
Ling-Chu Chang's innovative work in anticancer research highlights his commitment to improving cancer treatment options. His patents reflect a dedication to scientific advancement and the potential to save lives through effective therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile